Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Induction of aldo-keto reductases (AKR1C1 and AKR1C3) abolishes the efficacy of daunorubicin chemotherapy for leukemic U937 cells.

Matsunaga T, Yamaguchi A, Morikawa Y, Kezuka C, Takazawa H, Endo S, El-Kabbani O, Tajima K, Ikari A, Hara A.

Anticancer Drugs. 2014 Apr 16. [Epub ahead of print]

PMID:
24743520
[PubMed - as supplied by publisher]
2.

Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers.

Matsunaga T, Hojo A, Yamane Y, Endo S, El-Kabbani O, Hara A.

Chem Biol Interact. 2013 Feb 25;202(1-3):234-42. doi: 10.1016/j.cbi.2012.09.024. Epub 2012 Nov 16.

PMID:
23165153
[PubMed - indexed for MEDLINE]
3.

The reactive oxygen species--and Michael acceptor-inducible human aldo-keto reductase AKR1C1 reduces the alpha,beta-unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene.

Burczynski ME, Sridhar GR, Palackal NT, Penning TM.

J Biol Chem. 2001 Jan 26;276(4):2890-7. Epub 2000 Nov 1.

PMID:
11060293
[PubMed - indexed for MEDLINE]
Free Article
4.

Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.

Rao J, Xu DR, Zheng FM, Long ZJ, Huang SS, Wu X, Zhou WH, Huang RW, Liu Q.

J Transl Med. 2011 May 19;9:71. doi: 10.1186/1479-5876-9-71.

PMID:
21595920
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29.

Ebert B, Kisiela M, Wsól V, Maser E.

Chem Biol Interact. 2011 May 30;191(1-3):239-49. doi: 10.1016/j.cbi.2010.12.026. Epub 2011 Jan 6.

PMID:
21215737
[PubMed - indexed for MEDLINE]
6.

Anthracycline resistance mediated by reductive metabolism in cancer cells: The role of aldo-keto reductase 1C3.

Hofman J, Malcekova B, Skarka A, Novotna E, Wsol V.

Toxicol Appl Pharmacol. 2014 Aug 1;278(3):238-48. doi: 10.1016/j.taap.2014.04.027. Epub 2014 May 14.

PMID:
24832494
[PubMed - in process]
7.

Aldo-keto reductases mediate constitutive and inducible protection against aldehyde toxicity in human neuroblastoma SH-SY5Y cells.

Lyon RC, Li D, McGarvie G, Ellis EM.

Neurochem Int. 2013 Jan;62(1):113-21. doi: 10.1016/j.neuint.2012.10.007. Epub 2012 Oct 22.

PMID:
23084985
[PubMed - indexed for MEDLINE]
8.

9,10-phenanthrenequinone induces monocytic differentiation of U937 cells through regulating expression of aldo-keto reductase 1C3.

Matsunaga T, Hosogai M, Arakaki M, Endo S, El-Kabbani O, Hara A.

Biol Pharm Bull. 2012;35(9):1598-602.

PMID:
22975515
[PubMed - indexed for MEDLINE]
Free Article
10.

Dexrazoxane has no impact on sensitivity of childhood leukemic blasts to daunorubicin.

Styczynski J, Wysocki M, Balwierz W, Kowalczyk JR.

Leukemia. 2002 May;16(5):820-5. Erratum in: Leukemia 2002 Nov;16(11):2346.

PMID:
11986942
[PubMed - indexed for MEDLINE]
Free Article
11.

Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3.

Beranič N, Gobec S, Rižner TL.

Chem Biol Interact. 2011 May 30;191(1-3):227-33. doi: 10.1016/j.cbi.2010.12.012. Epub 2010 Dec 21.

PMID:
21182831
[PubMed - indexed for MEDLINE]
12.

Inducible protection of human astrocytoma 1321N1 cells against hydrogen peroxide and aldehyde toxicity by 7-hydroxycoumarin is associated with the upregulation of aldo-keto reductases.

Li D, Ellis EM.

Neurotoxicology. 2012 Oct;33(5):1368-74. doi: 10.1016/j.neuro.2012.08.015. Epub 2012 Sep 8.

PMID:
22964423
[PubMed - indexed for MEDLINE]
13.

AKRs expression in peripheral blood lymphocytes from smokers: the role of body mass index.

Barrón-Vivanco BS, Rothenberg SJ, Medina-Díaz IM, Robledo-Marenco L, Rojas-García AE, Hernández-Cadena L, Poblete-Naredo I, Elizondo G, Albores A.

Hum Exp Toxicol. 2013 Apr;32(4):418-26. doi: 10.1177/0960327112455071. Epub 2012 Aug 7.

PMID:
22872607
[PubMed - indexed for MEDLINE]
14.

Study on the bone marrow mesenchymal stem cells induced drug resistance in the U937 cells and its mechanism.

Lin YM, Zhang GZ, Leng ZX, Lu ZX, Bu LS, Gao S, Yang SJ.

Chin Med J (Engl). 2006 Jun 5;119(11):905-10.

PMID:
16780769
[PubMed - indexed for MEDLINE]
Free Article
15.

Daunorubicin metabolism in leukemic cells isolated from patients with acute myeloid leukemia.

Bogason A, Masquelier M, Lafolie P, Skogastierna C, Paul C, Gruber A, Vitols S.

Drug Metab Lett. 2010 Dec;4(4):228-32.

PMID:
20670211
[PubMed - indexed for MEDLINE]
16.

Optimization of PKH67 labeling conditions for proliferation monitoring in daunorubicin-treated leukemic cells.

Barbier M, Morjani H, Muirhead KA, Ronot X, Boutonnat J.

Oncol Rep. 2005 Aug;14(2):553-9.

PMID:
16012744
[PubMed - indexed for MEDLINE]
17.

Anthracycline secondary alcohol metabolite formation in human or rabbit heart: biochemical aspects and pharmacologic implications.

Mordente A, Minotti G, Martorana GE, Silvestrini A, Giardina B, Meucci E.

Biochem Pharmacol. 2003 Sep 15;66(6):989-98.

PMID:
12963485
[PubMed - indexed for MEDLINE]
18.

Identification of aldo-keto reductases as NRF2-target marker genes in human cells.

Jung KA, Choi BH, Nam CW, Song M, Kim ST, Lee JY, Kwak MK.

Toxicol Lett. 2013 Mar 27;218(1):39-49. doi: 10.1016/j.toxlet.2012.12.026. Epub 2013 Jan 7.

PMID:
23305850
[PubMed - indexed for MEDLINE]
19.

Aldo-keto reductase 1C subfamily genes in skin are UV-inducible: possible role in keratinocytes survival.

Marín YE, Seiberg M, Lin CB.

Exp Dermatol. 2009 Jul;18(7):611-8. doi: 10.1111/j.1600-0625.2008.00839.x. Epub 2009 Mar 6.

PMID:
19320734
[PubMed - indexed for MEDLINE]
20.

Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines.

Bailly JD, Muller C, Jaffrézou JP, Demur C, Gassar G, Bordier C, Laurent G.

Leukemia. 1995 May;9(5):799-807.

PMID:
7769842
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk